Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

337 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Timing to imaging and surgery after neoadjuvant therapy for breast cancer.
Grubstein A, Rapson Y, Stemmer SM, Allweis T, Wolff-Bar M, Borshtein S, Eden S, Tamir S, Atar E, Sharon E, Shochat T, Yerushalmi R. Grubstein A, et al. Among authors: sharon e. Clin Imaging. 2021 Mar;71:24-28. doi: 10.1016/j.clinimag.2020.10.043. Epub 2020 Nov 5. Clin Imaging. 2021. PMID: 33171362
Rate of breast biopsy referrals in female BRCA mutation carriers aged 50 years or more: a retrospective comparative study and matched analysis.
Pomerantz A, Tsoref D, Grubstein A, Wadhawker S, Rapson Y, Gadiel I, Goldvaser H, Feldhamer I, Hammerman A, Shochat T, Sharon E, Kedar I, Yerushalmi R. Pomerantz A, et al. Among authors: sharon e. Breast Cancer Res Treat. 2022 Jun;193(2):507-514. doi: 10.1007/s10549-021-06498-9. Epub 2022 Apr 7. Breast Cancer Res Treat. 2022. PMID: 35391652 Free PMC article.
3,3-Diindolylmethane (DIM): a nutritional intervention and its impact on breast density in healthy BRCA carriers. A prospective clinical trial.
Yerushalmi R, Bargil S, Ber Y, Ozlavo R, Sivan T, Rapson Y, Pomerantz A, Tsoref D, Sharon E, Caspi O, Grubsrein A, Margel D. Yerushalmi R, et al. Among authors: sharon e. Carcinogenesis. 2020 Oct 15;41(10):1395-1401. doi: 10.1093/carcin/bgaa050. Carcinogenesis. 2020. PMID: 32458980 Free PMC article. Clinical Trial.
Perioperative COX-2 and β-Adrenergic Blockade Improves Metastatic Biomarkers in Breast Cancer Patients in a Phase-II Randomized Trial.
Shaashua L, Shabat-Simon M, Haldar R, Matzner P, Zmora O, Shabtai M, Sharon E, Allweis T, Barshack I, Hayman L, Arevalo J, Ma J, Horowitz M, Cole S, Ben-Eliyahu S. Shaashua L, et al. Among authors: sharon e. Clin Cancer Res. 2017 Aug 15;23(16):4651-4661. doi: 10.1158/1078-0432.CCR-17-0152. Epub 2017 May 10. Clin Cancer Res. 2017. PMID: 28490464 Free PMC article. Clinical Trial.
Premature ovarian aging in BRCA carriers: a prototype of systemic precocious aging?
Ben-Aharon I, Levi M, Margel D, Yerushalmi R, Rizel S, Perry S, Sharon E, Hasky N, Abir R, Fisch B, Tobar A, Shalgi R, Stemmer SM. Ben-Aharon I, et al. Among authors: sharon e. Oncotarget. 2018 Mar 23;9(22):15931-15941. doi: 10.18632/oncotarget.24638. eCollection 2018 Mar 23. Oncotarget. 2018. PMID: 29662617 Free PMC article.
A novel role for an old target: CD45 for breast cancer immunotherapy.
Raiter A, Zlotnik O, Lipovetsky J, Mugami S, Dar S, Lubin I, Sharon E, Cohen CJ, Yerushalmi R. Raiter A, et al. Among authors: sharon e. Oncoimmunology. 2021 May 25;10(1):1929725. doi: 10.1080/2162402X.2021.1929725. Oncoimmunology. 2021. PMID: 34104545 Free PMC article.
A Dedicated Follow-Up Clinic for BRCA Mutation Carriers.
Yerushalmi R, Rizel S, Zoref D, Sharon E, Eitan R, Sabah G, Grubstein A, Rafson Y, Cohen M, Magen A, Birenboim I, Margel D, Ozlavo R, Sulkes A, Brenner B, Perry S. Yerushalmi R, et al. Among authors: sharon e. Isr Med Assoc J. 2016 Sep;18(9):549-552. Isr Med Assoc J. 2016. PMID: 28471604 Free article.
337 results